BioHealth News Archive
MaxCyte Begins Dosing in First Clinical Trial in Solid Tumors – American Pharmaceutical Review
MaxCyte announced the first patient has been dosed in its Phase I dose-escalation clinical trial in the United States with the company's lead wholly-owned…
Read More
Jonathan Aberman: You want funding? Follow this advice. – Washington Business Journal
However long a business has operated, investors will look for three big things if they are going to invest. {iframe}https://www.bizjournals.com/washington/news/2018/10/11/jonathan-aberman-you-want-funding-follow-this.html?ana=e_me_set2&s=newsletter&ed=2018-10-11&u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1539610411&j=84341881{/iframe}
Read More
Healthcare companies rake in $23B in venture capital funding
U.S. healthcare companies have collected $23.4 billion in venture capital funding this year — already surpassing the amount the sector obtained in all of…
Read More
Innovation challenges are all the rage with pharma, and they’re likely here to stay: study | FiercePharma
The number of open innovation challenges in pharma grows by the day. But what’s driving them? That’s what Luminary Labs wanted to know. So…
Read More
Inaugural Investment Conference Marks Inflection Point for the BioHealth Capital Region · BioBuzz
The first Biohealth Capital Region Investment Conference kicks off this week in Montgomery County. The conference marks an important inflection point for a region…
Read More
Top 10 European Biopharma Clusters, October 2018 – GEN
Europe’s biotech industry recently celebrated its growth and progress with more than 120 events taking place across 18 European countries September 24 –30, in…
Read More
VC Investment Jumps 51% Year-over-Year During Q3 – GEN
Biopharma venture capital activity maintained its red-hot pace during the third quarter of 2018, driven by a handful of deals exceeding $200 million, according…
Read More
Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1) · BioBuzz
This has been a year marked by many notable biotech deals, especially in the immunotherapy market. One deal, in particular, has generated more local…
Read More
15 emerging technologies that could reduce global catastrophic biological risks – EurekAlert! Science News
Johns Hopkins Center for Health Security authors recommend dedicated attention to and investment in 'potentially transformative' technologies to complement traditional approaches to prevention, preparedness,…
Read More
CIT Announces FY2019 Solicitation for Commonwealth Research Commercialization Fund
The Center for Innovative Technology (CIT) announced today the Commonwealth Research Commercialization Fund (CRCF) Request for Proposals (RFP) for FY2019. {iframe}https://globenewswire.com/news-release/2018/10/09/1618739/0/en/CIT-Announces-FY2019-Solicitation-for-Commonwealth-Research-Commercialization-Fund.html{/iframe}
Read More
2018 Oncologist National Workforce Study
Some big cities could see shortages of cancer specialists in the coming decade, according to a new analysis by Doximity, a social network for…
Read More
D.C. area could see record venture funding year – Washington Business Journal
The local funding environment is mirroring the gangbusters national funding situation. {iframe}https://www.bizjournals.com/washington/news/2018/10/09/the-biggest-venture-capital-year-ever-for-reater.html?ana=e_me_set1&s=newsletter&ed=2018-10-09&u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1539609280&j=84291361{/iframe}
Read More
Valneva Receives FDA Approval for Accelerated Vaccine Dosing Schedule for IXIARO® – Press Release – Digital Journal
Valneva USA, the U.S. subsidiary of global vaccine biotech company Valneva SE, today announced U.S. Food and Drug Administration (FDA) approval of an accelerated dosing…
Read More
SBIR Office Hours
BioHealth Innovation sponsors quarterly office hours in Montgomery County and at Johns Hopkins Fast Forward (Fast Forward hours are for JHU innovators only). BioHealth…
Read More
SBIR Funding Assistance
If you and your team are located in the BioHealth Capital Region, BHI may prepay for experts to help you improve your SBIR and…
Read More